Clinical Trial Details
— Status: Active, not recruiting
Administrative data
| NCT number |
NCT05697172 |
| Other study ID # |
2021-011 |
| Secondary ID |
|
| Status |
Active, not recruiting |
| Phase |
N/A
|
| First received |
|
| Last updated |
|
| Start date |
December 15, 2022 |
| Est. completion date |
March 30, 2024 |
Study information
| Verified date |
February 2024 |
| Source |
Laureate Institute for Brain Research, Inc. |
| Contact |
n/a |
| Is FDA regulated |
No |
| Health authority |
|
| Study type |
Interventional
|
Clinical Trial Summary
The investigators propose to use low-intensity transcranial focused ultrasound (LIFU), a
novel neuromodulation method, to probe the causal involvement of individually defined
components of an anteromedial brain circuit in the processing of self-referential thoughts,
and the production of repetitive negative thinking (RNT), a prominent transdiagnostic
manifestation with adverse clinical consequences. The investigators hypothesize that real vs.
sham low-intensity sonication of individually-defined anteromedial structures connecting
medial orbitofrontal and anterior cingulate cortices with ventral striatum and anterior
thalamus will show reduced initiation or maintenance of RNT as measured by (1) Brief State
Rumination Inventory (BSRI) scores and distress associated to repetitive negative thoughts,
and (2) improvement of the affective valence associated to self-referential adjectives, and
that these changes will be associated with decreased connectivity between structures
mentioned above. The present early feasibility study is an initial step that aims to
determine its feasibility and help with the planning of a larger study addressed at actual
hypothesis testing.
Description:
Depression represents a remarkable public health burden, accounting for a large amount of
disability and societal costs, comparable to prevalent diseases in other areas of medicine.
This is partly due to unsatisfactory outcomes of well-established therapies, including
psychotropic drugs and different types of psychotherapy. As a response to this problem,
therapeutics in psychiatry is moving from drug manipulation of neurotransmitter systems to
modulation of brain circuits selectively involved in specific symptoms of depression. These
efforts have been partially hampered, however, by heterogeneity of clinical manifestations in
these disorders, such that different symptoms are hypothesized to be maintained by specific
circuit-level dysfunctions, as well as by significant interindividual variation in those
brain circuits, which calls for personalized approaches to achieve their successful
modulation. Thus far, the efforts to accomplish individualized and precise modulation of
aberrant circuits responsible for the expression of depression and anxiety symptoms have
encountered three important, mutually related problems. First, widely available noninvasive
neuromodulation techniques such as repetitive transcranial magnetic stimulation (rTMS) have
poor spatial resolution and only reach superficial areas of the brain, which impedes the
precise modulation of circuits that involve deep, minute subcortical gray matter structures
and/or white matter connecting tracts. Second, surgical deep-brain stimulation procedures are
more accurate but are too costly and risky to be implemented in any moderately sized
proof-of-concept study at present. Third, it is unlikely that modification of the activity of
a discrete brain circuit will target the entire complex behavioral macro of major depression.
The investigators therefore chose to target a single measurable and replicable construct of
depression, repetitive negative thinking (RNT). RNT is a transdiagnostic clinical
manifestation that cuts across a variety of internalizing psychiatric disorders, but in the
case of depression, it is associated with persistent symptoms, treatment resistance,
proneness to relapse after treatment, and more suicidal ideation, behavior, and completed
suicides. With the help of an emerging technology device recently acquired by LIBR, which can
produce focused, reversible and noninvasive neuromodulation in deep brain structures
(low-intensity transcranial focused ultrasound, tfUS), the investigators will probe the
causal role of individually-identified circuits in the modulation of (a) the generation and
maintenance of repetitive negative thinking (RNT), and (b) affective processing of
self-referential adjectives. Specifically, the investigators will put to test the hypotheses
that RNT and the affective load of self-referential adjectives can be improved by modulating
components of an anteromedial brain circuit, identified on an individual basis as associated
with high levels of RNT. Therefore, this project has two distinct phases. First, the
investigators will use advanced structural-functional connectivity analysis techniques to
define anatomical tracts that support functional connectivity alterations associated with
high RNT. The investigators will refine and adjust results of whole-brain analyses, by
focusing also on overlapping anatomical components of tracts pertaining to three
well-established, historical psychosurgical targets of antidepressant and obsessional
thinking treatment. Second, the investigators will employ the resulting regions of interest
to inform the choice of the target(s) for tfUS neuromodulation, probing its effects on 1)
neural processing of self-referential affective adjectives, 2) functional connectivity
between regions known to have an anatomical connection in the individual participant, and 3)
measures of RNT and clinical depression, including the degree of distress associated to the
thought/s subjected to RNT. The investigators are in an ideal position to accomplish these
objectives, given their experience with clinical management of these disorders, with the use
of neuromodulation techniques, and expertise in the use of state-of-the-art structural and
functional neuroimaging techniques, psychophysiological tools, and computational psychiatry
methods.
